Pullen J K, Hunt H D, Pease L R
Department of Immunology, Mayo Clinic, Rochester, MN 55905.
J Immunol. 1991 Apr 1;146(7):2145-51.
The ability of OVA-specific H-2Kb-restricted CTL to recognize the defined OVA258-276 peptide in the context of the Kbm mutants and variants of these mutants was examined to determine how specific variations in the Ag recognition site-influenced peptide presentation to these CTL. L cells expressing Kb or Kbm10 were equally capable of presenting the OVA peptide to Kb-restricted, OVA-specific bulk CTL, whereas L cell clones expressing Kbm8 or Kbm1 showed little to no capacity to present this peptide. L cell transfectants expressing Kbm3 and Kbm23 consistently demonstrated an intermediate to low level of presentation to bulk OVA-specific CTL. Dissection of the Kbm8 mutant revealed that cells expressing Kbm8-22 (Tyr----Phe) and/or Kbm8-24 (Glu----Ser) presented the OVA peptide significantly less well than the Kb-presenting molecule. Presentation of OVA by cells expressing Kbm8-23,30 (Met----Ile) (Asp----Asn), Kbm8-23 (Met----Ile), and Kbm8-30 (Asp----Asn) was equivalent to Kb presentation. Another mutation designated as Kbm5, that has a substitution at position 116 (Tyr----Phe), demonstrated an intermediate to high ability to present OVA258-276 to an OVA-specific CTL line. The Kbm3, Kbm11, and Kbm23 mutants were unable to present the OVA peptide to this same CTL line. Dissection of these mutants showed that the substitution at position 77 (Asp----Ser), which is shared by all three mutants, was responsible for their inability to present the peptide. A second Kb-restricted CTL line was able to recognize OVA in the context of the Asp----Ser substitution at position 77. The results of this analysis suggest that the OVA258-276 peptide interacts with multiple regions within the Ag recognition site of the Kb class I protein.
研究了卵清蛋白(OVA)特异性H-2Kb限制性细胞毒性T淋巴细胞(CTL)在Kbm突变体及其变体背景下识别特定OVA258-276肽的能力,以确定抗原识别位点的特定变异如何影响向这些CTL呈递肽。表达Kb或Kbm10的L细胞同样能够将OVA肽呈递给Kb限制性、OVA特异性的大量CTL,而表达Kbm8或Kbm1的L细胞克隆几乎没有呈递该肽的能力。表达Kbm3和Kbm23的L细胞转染子始终表现出向大量OVA特异性CTL呈递的水平处于中等至低水平。对Kbm8突变体的分析表明,表达Kbm8-22(酪氨酸→苯丙氨酸)和/或Kbm8-24(谷氨酸→丝氨酸)的细胞呈递OVA肽的能力明显低于呈递Kb的分子。表达Kbm8-23,30(甲硫氨酸→异亮氨酸)(天冬氨酸→天冬酰胺)、Kbm8-23(甲硫氨酸→异亮氨酸)和Kbm8-30(天冬氨酸→天冬酰胺)的细胞呈递OVA的能力与呈递Kb的能力相当。另一个命名为Kbm5的突变体在第116位(酪氨酸→苯丙氨酸)有一个替换,表现出向OVA特异性CTL系呈递OVA258-276的能力处于中等至高。Kbm3、Kbm11和Kbm23突变体无法将OVA肽呈递给同一CTL系。对这些突变体的分析表明,所有三个突变体共有的第77位(天冬氨酸→丝氨酸)的替换导致它们无法呈递该肽。第二条Kb限制性CTL系能够在第77位天冬氨酸→丝氨酸替换的背景下识别OVA。该分析结果表明,OVA258-276肽与I类Kb蛋白的抗原识别位点内的多个区域相互作用。